The Importance of Cardiac Magnetic Resonance in the Assessment Risk of Cardiac Arrhythmias in Patients with Arterial Hypertension
- PMID: 39336870
- PMCID: PMC11432360
- DOI: 10.3390/jcm13185383
The Importance of Cardiac Magnetic Resonance in the Assessment Risk of Cardiac Arrhythmias in Patients with Arterial Hypertension
Abstract
Objectives: Arterial hypertension (AH) is one of the major risk factors for cardiovascular diseases. An association between untreated AH and arrhythmia is observed. Cardiac magnetic resonance (CMR) assesses myocardial fibrosis by detecting foci of late gadolinium enhancement (LGE). Clinical significance of LGE at the right ventricular insertion point (RVIP) is not fully established. This study aimed to assess the relationship between the presence of LGE at the RVIP determined by CMR and the incidence of arrhythmia in a group suffering from arterial hypertension. Methods: The study group consisted of 81 patients with AH (37 men and 44 women, age: 56.7 ± 7.1 years). All subjects underwent CMR and 24 h Holter ECG monitoring. Two subgroups were distinguished in the study group based on the criterion of the presence of LGE at the RVIP in CMR. The RVIP+ subgroup consisted of patients with LGE at the RVIP, while the RVIP- group consisted of patients without LGE at the RVIP. Results: The RVIP+ subgroup was characterized by higher maximum and minimum heart rates in 24 h Holter ECG recordings compared to the RVIP- subgroup (p < 0.05). The RVIP+ subgroup had a statistically significantly higher number of single premature supraventricular beats, supraventricular tachycardias, and single premature ventricular beats than the RVIP- subgroup (p < 0.05). Regression analysis documented that a longer duration of AH (counted from diagnosis) as well as the occurrence of LGE at the RVIP (assessed by CMR) are independent risk factors for arrhythmia (p < 0.05). Conclusions: Due to the possibility of detecting LGE at the RVIP, CMR may be a useful diagnostic method in estimating the risk of arrhythmias in the group of patients with AH.
Keywords: arrhythmias; arterial hypertension; cardiac magnetic resonance; right ventricular insertion point.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.J Cardiovasc Magn Reson. 2012 Feb 1;14(1):11. doi: 10.1186/1532-429X-14-11. J Cardiovasc Magn Reson. 2012. PMID: 22296860 Free PMC article.
-
Clinical importance of late gadolinium enhancement at right ventricular insertion points in otherwise normal hearts.Int J Cardiovasc Imaging. 2020 May;36(5):913-920. doi: 10.1007/s10554-020-01783-y. Epub 2020 Feb 6. Int J Cardiovasc Imaging. 2020. PMID: 32026265
-
Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study.PLoS One. 2018 Nov 28;13(11):e0208100. doi: 10.1371/journal.pone.0208100. eCollection 2018. PLoS One. 2018. PMID: 30485353 Free PMC article.
-
Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18. Eur Radiol. 2015. PMID: 25597022
-
Prognostic Value of Late Gadolinium Enhancement Detected on Cardiac Magnetic Resonance in Cardiac Sarcoidosis.JACC Cardiovasc Imaging. 2023 Mar;16(3):345-357. doi: 10.1016/j.jcmg.2022.10.018. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36752432
References
-
- Mancia G., Kreutz R., Brunström M., Burnier M., Grassi G., Januszewicz A., Muiesan M.L., Tsioufis K., Agabiti-Rosei E., Algharably E.A.E., et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) J. Hypertens. 2023;41:1874–2071. doi: 10.1097/HJH.0000000000003480. - DOI - PubMed
LinkOut - more resources
Full Text Sources